The National Stock Exchange of India (NSE) has received a rare 'sell' recommendation from domestic brokerage Dolat Capital Markets ahead of its long-anticipated initial public offering, with analysts warning that tightening regulations in the equity derivatives segment could materially dent the exchange's growth trajectory and justify a significant valuation discount.

The Bearish Call

Dolat Capital initiated coverage on NSE with a target price of ₹1,550 — roughly 26% below the exchange's prevailing unlisted market price of approximately ₹2,085. Recommendations on unlisted companies are uncommon in India, making this bearish initiation particularly noteworthy as NSE prepares for what is widely expected to be India's largest-ever IPO.

Analysts led by Punit Bahlani flagged that a decline in proprietary trading volumes and the loss of market share in index options are expected to constrain NSE's earnings growth over the coming years. The brokerage projects NSE's options trading turnover will contract at a compound annual rate of around 4% between FY26 and FY29, as stricter rules, softer retail participation, and a weaker market cycle collectively suppress activity.

Valuation vs. Peers

NSE is currently valued at approximately ₹5.2 lakh crore in the unlisted market. However, according to unlisted share-trading platform UnlistedZone, its shares have declined around 3% over the past 12 months. Dolat Capital's report noted that NSE's unlisted market valuation is richer than several global exchange peers, despite relatively slower profit growth — a gap the brokerage argues leaves little room for upside even under an optimistic scenario.

The brokerage acknowledged that NSE retains a strong long-term structural growth story, given India's expanding retail investor base and deepening capital markets. The concern, analysts said, is one of timing and price — the current unlisted premium does not adequately account for near-term regulatory headwinds.

IPO Delays and Legal Overhang

NSE's IPO has been in the pipeline for years, repeatedly held back by unresolved regulatory and legal matters. Chief among these are the long-running co-location and dark fibre cases. In its draft red herring prospectus (DRHP), NSE disclosed a proposal to pay ₹1,491.21 crore to settle regulatory proceedings with the Securities and Exchange Board of India (SEBI).

The exchange has stated that these matters remain pending before the Supreme Court, SEBI, and other judicial forums, and have been disclosed under the material litigation section of the IPO documents. The unresolved cases add a layer of legal uncertainty that analysts say complicates any near-term listing timeline.

What This Means for Investors

This is the first publicly known 'sell' initiation on NSE ahead of its IPO, and it arrives at a sensitive moment. Retail and institutional investors who have accumulated NSE shares in the unlisted market at prices near or above ₹2,085 face the prospect of listing-day losses if Dolat Capital's target proves accurate. The broader signal from the report is that regulatory risk in India's derivatives ecosystem — already reshaped by recent SEBI curbs on index options — is not yet fully priced into NSE's unlisted valuation.

With the IPO timeline still uncertain and legal proceedings unresolved, market participants will be watching for any SEBI clearance or Supreme Court order that could unlock the listing process.